Science Explorer Back to mapMap
Discussion
Company · Orlando · United States

Enveda Therapeutics (United States)

Research works
32
▲ 65% vs 2018-21
Citations
665
20.9 per fractional work
Top-10% rate
21.6%
all institutions 10.0%
Open access
72%
world 40%
International
20%
world 18%

Not ranked overall: Enveda Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Enveda Therapeutics (United States) work in?

In all years, 47% of research at Enveda Therapeutics (United States) is in Life Sciences, 26% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (39%), Medicine (24%), Computer Science (12%). It does 2.3× the world's share of Life Sciences.

Life Sciences: 15 fractional works · 46.9% of its workBiochemistry, Genetics and Molecular Biology: 13 fractional works · 39.5% of its workMolecular Biology: 10 fractional works · 32.4% of its workBiophysics: 1 fractional works · 3.1% of its workCell Biology: 0 fractional works · 1.6% of its workGenetics: 0 fractional works · 1.2% of its workCancer Research: 0 fractional works · 0.6% of its workEndocrinology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 1 fractional works · 4.2% of its workPlant Science: 1 fractional works · 3.7% of its workInsect Science: 0 fractional works · 0.5% of its workImmunology and Microbiology: 1 fractional works · 1.8% of its workImmunology: 0 fractional works · 1.3% of its workMicrobiology: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.2% of its workPharmaceutical Science: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.3% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workPhysical Sciences: 8 fractional works · 26.3% of its workComputer Science: 4 fractional works · 12.3% of its workComputational Theory and Mathematics: 2 fractional works · 7.5% of its workArtificial Intelligence: 1 fractional works · 2.5% of its workInformation Systems: 0 fractional works · 1.1% of its workSoftware: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 3 fractional works · 10.0% of its workSpectroscopy: 3 fractional works · 7.9% of its workAnalytical Chemistry: 0 fractional works · 1.0% of its workOrganic Chemistry: 0 fractional works · 1.0% of its workEngineering: 0 fractional works · 1.6% of its workBiomedical Engineering: 0 fractional works · 1.6% of its workMaterials Science: 0 fractional works · 1.3% of its workMaterials Chemistry: 0 fractional works · 1.3% of its workEnvironmental Science: 0 fractional works · 1.0% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.0% of its workHealth Sciences: 8 fractional works · 25.2% of its workMedicine: 8 fractional works · 24.4% of its workOncology: 4 fractional works · 11.1% of its workEpidemiology: 1 fractional works · 4.3% of its workNeurology: 0 fractional works · 1.2% of its workPsychiatry and Mental health: 0 fractional works · 1.1% of its workBiochemistry: 0 fractional works · 1.0% of its workPharmacology: 0 fractional works · 1.0% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.9% of its workOphthalmology: 0 fractional works · 0.8% of its workInfectious Diseases: 0 fractional works · 0.7% of its workNephrology: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 0.2% of its workGeneral Health Professions: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 1.7% of its workDecision Sciences: 0 fractional works · 1.0% of its workStatistics, Probability and Uncertainty: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 0.4% of its workEducation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workEconomics and Econometrics: 0 fractional works · 0.2% of its workALL ITS WORKEnvedaTherapeutics…32fractional works, all years
Life Sciences47%Physical Sciences26%Health Sciences25%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1339.5%
    2. Agricultural and Biological Sciences14.2%
    3. Immunology and Microbiology11.8%
    4. Pharmacology, Toxicology and Pharmaceutics01.2%
    5. Neuroscience00.3%
    1. Computer Science412.3%
    2. Chemistry310.0%
    3. Engineering01.6%
    4. Materials Science01.3%
    5. Environmental Science01.0%
    1. Medicine824.4%
    2. Nursing00.5%
    3. Health Professions00.2%
    1. Decision Sciences01.0%
    2. Social Sciences00.4%
    3. Economics, Econometrics and Finance00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.05× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.56× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 1.24× its world share, 0 worksImmunology and Micro…Neuroscience: 0.26× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.41× its world share, 0 worksPharmacology, Toxico…Chemistry: 10.19× its world share, 3 worksChemistryComputer Science: 2.31× its world share, 4 worksComputer ScienceEngineering: 0.11× its world share, 0 worksEngineeringEnvironmental Science: 0.34× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.48× its world share, 0 worksMaterials ScienceHealth Professions: 0.13× its world share, 0 worksHealth ProfessionsMedicine: 0.44× its world share, 2 worksMedicineNursing: 1.70× its world share, 0 worksNursingDecision Sciences: 1.73× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.16× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 10.2×. Every wedge is a field page.

All 16 fields, with their numbers
  1. Chemistry10.19×3 works
  2. Biochemistry, Genetics and Molecular Biology7.56×8 works
  3. Pharmacology, Toxicology and Pharmaceutics5.41×0 works
  4. Computer Science2.31×4 works
  5. Decision Sciences1.73×0 works
  6. Nursing1.70×0 works
  7. Immunology and Microbiology1.24×0 works
  8. Agricultural and Biological Sciences1.05×1 works
  9. Materials Science0.48×0 works
  10. Medicine0.44×2 works
  11. Environmental Science0.34×0 works
  12. Neuroscience0.26×0 works
  13. Economics, Econometrics and Finance0.16×0 works
  14. Health Professions0.13×0 works
  15. Engineering0.11×0 works
  16. Social Sciences0.05×0 works

Who are the top researchers at Enveda Therapeutics (United States)?

Ranked on the quality score, Brian H. White, David Healey and Kerry A. Whalen lead among researchers whose main affiliation is Enveda Therapeutics (United States).

  1. 1 Brian H. White United States · #921,819 worldwide 804 citations · 49 works
  2. 2 David Healey United States · #1,283,875 worldwide 297 citations · 35 works
  3. 3 Kerry A. Whalen United States · #1,375,181 worldwide 240 citations · 53 works
  4. 4 Viswa Colluru United States · #1,461,870 worldwide 268 citations · 20 works
  5. 5 Samantha Perino United States · #1,539,102 worldwide 224 citations · 82 works
  6. 6 Kristina Kriksciukaite United States · #2,002,233 worldwide 323 citations · 44 works
  7. 7 Beata Sweryda‐Krawiec United States · #2,150,664 worldwide 538 citations · 38 works
  8. 8 Abhishek Patel United States · #3,876,654 worldwide 174 citations · 39 works
All ranked researchers at Enveda Therapeutics (United States)

What are the most cited papers from Enveda Therapeutics (United States)?

The most cited paper from Enveda Therapeutics (United States) is "Cancer nanomedicine: progress, challenges and opportunities" (Jinjun Shi, Philip W. Kantoff, Richard F. Wooster et al., 2016), with 5,834 citations. Next come "New software tools, databases, and resources in metabolomics: updates from 2020" (237) and "Natural Products Have Increased Rates of Clinical Trial Success throughout the Drug Development Process" (92).

Most cited papers
#PaperReleasedCitations
1 Cancer nanomedicine: progress, challenges and opportunities Jinjun Shi, Philip W. Kantoff, Richard F. Wooster et al. · Nature reviews. Cancer ReviewOpen access 11 Nov 2016 5,834
2 New software tools, databases, and resources in metabolomics: updates from 2020 Biswapriya B. Misra · Metabolomics Open access May 2021 237
3 Natural Products Have Increased Rates of Clinical Trial Success throughout the Drug Development Process Daniel Domingo‐Fernándéz, Yojana Gadiya, António J. Preto et al. · Journal of Natural Products Open access 6 Jul 2024 92
4 Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer Kerry A. Whalen, Brian H. White, James M. Quinn et al. · Molecular Cancer Therapeutics 24 Oct 2019 76
5 On the influence of several factors on pathway enrichment analysis Sarah Mubeen, Alpha Tom Kodamullil, Martin Hofmann‐Apitius et al. · Briefings in Bioinformatics Open access 14 Apr 2022 75
All 66 most cited papers, with filters and sorting

Which keywords describe research at Enveda Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Biomarkers, Mass Spectrometry, Machine Learning, Genomics, Chemotherapy, Data Analysis, Precision Medicine and Cancer Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 33 words, with their numbers
  1. Biomarkers4▲ 23×3 topics
  2. Machine Learning4▲ 6.4×6 topics
  3. Mass Spectrometry4▲ 64×3 topics
  4. Genomics4▲ 32×2 topics
  5. Chemotherapy3▲ 12×3 topics
  6. Data Analysis3▲ 26×2 topics
  7. Cancer Therapy2▲ 12×5 topics
  8. Human Metabolome Database2▲ 146×1 topic
  9. Metabolomics2▲ 146×1 topic
  10. Precision Medicine2▲ 26×2 topics
  11. Molecular Docking2▲ 53×1 topic
  12. Virtual Screening2▲ 107×1 topic
  13. Immunotherapy2▲ 10×3 topics
  14. Targeted Therapy2▲ 30×2 topics
  15. Proteomics2▲ 50×2 topics
  16. Genetic Mutations2▲ 11×2 topics
  17. Genomic Profiles2▲ 155×1 topic
  18. Small-Cell Lung Cancer2▲ 155×1 topic
  19. Bioinformatics2▲ 42×3 topics
  20. Neuroendocrine Tumors1▲ 110×1 topic
  21. Pancreatic Neuroendocrine Tumors1▲ 110×1 topic
  22. Deep Learning1▲ 1.93×3 topics
  23. Gene Expression1▲ 6.6×5 topics
  24. Isoprenoid Pathway1▲ 127×1 topic
  25. Terpenoid Biosynthesis1▲ 127×1 topic
  26. Electrospray1▲ 49×1 topic
  27. Ionization1▲ 49×1 topic
  28. Cell Death1▲ 16×4 topics
  29. Training1▲ 18×2 topics
  30. Big Data1▲ 5.9×1 topic
  31. Drug Discovery1▲ 7.9×2 topics
  32. Education1▲ 2.5×1 topic
  33. Medicinal Plants1▲ 8.4×2 topics

Which research topics does Enveda Therapeutics (United States) publish most on?

By volume in 2022-now: Metabolomics and Mass Spectrometry Studies, Computational Drug Discovery Methods, Plant biochemistry and biosynthesis and Mass Spectrometry Techniques and Applications.

  1. 1 Metabolomics and Mass Spectrometry Studies Molecular Biology 2 works
  2. 2 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
  3. 3 Plant biochemistry and biosynthesis Molecular Biology 1 works
  4. 4 Mass Spectrometry Techniques and Applications Spectroscopy 1 works
  5. 5 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 1 works
  6. 6 Ethnobotanical and Medicinal Plants Studies Plant Science 1 works
  7. 7 Advanced Proteomics Techniques and Applications Spectroscopy 1 works
  8. 8 Bioinformatics and Genomic Networks Molecular Biology 1 works
  9. 9 Cell Image Analysis Techniques Biophysics 0 works
  10. 10 Advanced Graph Neural Networks Artificial Intelligence 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.9%not open28.1%

World: 40% of research is openly available.

with international co-authors20.4%domestic only79.6%

World: 18% is written across borders.

How has Enveda Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 65% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Enveda Therapeutics (United States) as a percentage of every work published that year, 0.000045% in 2024.

still counting0.000050%0.00010%Enveda Therapeutics (United States)0.000096% in 20252020

Fractional works of Enveda Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Orlando

All research institutions in Orlando

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Enveda Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.